Laura Hamill
CIK 1751804 · EVP, Worldwide Commercial Ops · last filed 2025-09-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.83M
Companies
7
Total Filings
25
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JAZZ | Director | 6,933 | $230.56 | $1.60M | $0 | 2 | 2025-08-11 |
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 30,905 | $8.61 | $266.1K | $0 | 6 | 2025-07-02 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | — | $2.16 | — | $0 | 4 | 2023-08-31 |
| SCLXW | Director | — | $0.17 | — | $0 | 1 | 2023-01-17 |
| ANAB | Director | — | $56.07 | — | $0 | 5 | 2023-01-10 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 0 | $178.75 | $0 | $0 | 3 | 2021-11-22 |
| GILD | EVP, Worldwide Commercial Ops | 9,840 | $125.59 | $1.24M | $0 | 3 | 2019-05-10 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-19 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-14 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2021-12-28 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −474 | $0 | EDGAR |
| 2021-06-14 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-12 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +474 | $0 | EDGAR |
| 2020-09-17 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-24 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.